Literature DB >> 6092510

Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.

K Welte, M Andreeff, E Platzer, K Holloway, B Y Rubin, M A Moore, R Mertelsmann.   

Abstract

We investigated the effect of OKT3 antibody and interleukin 2 (IL-2) on Tac antigen expression and the proliferation of human peripheral blood mononuclear leukocytes. OKT3 monoclonal antibody at low, nonmitogenic concentrations (25 pg/ml) or IL-2 alone at optimal concentrations (20 U/ml) did not induce IL-2 receptor expression, as measured by Tac antibody or by T cell proliferation. However, costimulation with these concentrations of OKT3 antibody and IL-2 led to Tac antigen expression and T cell proliferation. These data suggest that the T cells are activated in two steps: OKT3 antibody at 25 pg/ml does not induce Tac antigen expression, but preactivates T cells to become responsive to IL-2. The addition of exogenous IL-2 then leads to expression of the IL-2 receptor, as recognized by Tac antibody, and to subsequent proliferation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092510      PMCID: PMC2187497          DOI: 10.1084/jem.160.5.1390

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

4.  Effect of mitomycin C on protein synthesis in human neoplastic cell lines.

Authors:  M I Lerman; M S Benyumovich
Journal:  Nature       Date:  1965-06-19       Impact factor: 49.962

5.  Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells.

Authors:  A P Grollman
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

8.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

9.  Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA.

Authors:  M Andreeff; Z Darzynkiewicz; T K Sharpless; B D Clarkson; M R Melamed
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

Review 10.  Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes.

Authors:  F W Ruscetti; R C Gallo
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

View more
  45 in total

1.  Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.

Authors:  M B Sztein; S A Serrate; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Role of monocytes in anti-CD3-induced T-cell DNA synthesis: effect of chloroquine and monensin on anti-CD3-induced human T-cell activation.

Authors:  B Vayuvegula; K Ohira; S Gollapudi; S Gupta
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

3.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

4.  Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.

Authors:  S Hashimoto; C C McCombs; J P Michalski
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrates isotype regulatory function.

Authors:  H Kimata; A Saxon
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

6.  Cytokine gene expression in normal human lymphocytes in response to stimulation.

Authors:  J Fan; P Nishanian; E C Breen; M McDonald; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

7.  Defective cell mediated immunity in sarcoidosis: effect of interleukin-2.

Authors:  D J Lyons; L Gao; E B Mitchell; D N Mitchell
Journal:  Thorax       Date:  1988-12       Impact factor: 9.139

8.  Specific inhibition of OKT3-driven T-cell mitogenesis by an anti HLA-class I monoclonal antibody.

Authors:  I Beckman; X Xiaoning; J Bradley
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

9.  Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease.

Authors:  S Kakumu; K Yoshioka; A Fuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1988-08

10.  A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma.

Authors:  P B Chapman; J E Kolitz; T B Hakes; J L Gabrilove; K Welte; V J Merluzzi; A Engert; E C Bradley; M Konrad; R Mertelsmann
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.